Prospective evaluation of the effect of deferasirox on hematologic response in transfusion-dependent patients with low-risk MDS and iron overload.

MLA

Rose, Christian, et al. “Prospective Evaluation of the Effect of Deferasirox on Hematologic Response in Transfusion-Dependent Patients with Low-Risk MDS and Iron Overload.” European Journal of Haematology, vol. 101, no. 2, Aug. 2018, pp. 165–73. EBSCOhost, https://doi.org/10.1111/ejh.13088.

APA

Rose, C., Lenoir, C., Gyan, E., Hacini, M., Amé, S., Corront, B., Beyne-Rauzy, O., Adiko, D., Loppinet, E., Ali-Ammar, N., Laribi, K., Wattel, E., Dreyfus, F., Roué, C. S., & Cheze, S. (2018). Prospective evaluation of the effect of deferasirox on hematologic response in transfusion-dependent patients with low-risk MDS and iron overload. European Journal of Haematology, 101(2), 165–173. https://doi.org/10.1111/ejh.13088

Chicago

Rose, Christian, Caroline Lenoir, Emmanuel Gyan, Maya Hacini, Shanti Amé, Bernadette Corront, Odile Beyne-Rauzy, et al. 2018. “Prospective Evaluation of the Effect of Deferasirox on Hematologic Response in Transfusion-Dependent Patients with Low-Risk MDS and Iron Overload.” European Journal of Haematology 101 (2): 165–73. doi:10.1111/ejh.13088.